Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
about
Brk is coamplified with ErbB2 to promote proliferation in breast cancerHypoxia-inducible factor 1 is activated by dysregulated cyclin E during mammary epithelial morphogenesis.Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.Cyclin E is stabilized in response to replication fork barriers leading to prolonged S phase arrest.A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels.The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F.The regulation of SIRT2 function by cyclin-dependent kinases affects cell motilityAdenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray.Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cells.Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment.Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2.CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.
P2860
Q28115616-23937B13-ED76-43EE-B778-BC6D73D6BFFBQ35192615-F1B7C26D-818E-4561-A4EB-2522B4C523BEQ36160032-B64CE6F3-1499-439F-8041-8BA7BB736099Q37467528-24021945-7847-43DA-9778-9883A9A79F7FQ39818985-32816646-8A91-4C63-89F0-CDD295C1DC76Q39943823-1F601FE2-FB2E-4481-A1B2-6FBF6E2015A0Q40003738-EA88AA10-358F-4824-B749-9CDC77BEE932Q40018751-A1E0228C-2EA8-4AE3-A7FE-BD39EB848937Q40230276-4318AE74-C44E-4950-8070-E7E0C293CC20Q40602827-422E131B-A710-4425-8638-7470683EE063Q43596756-8C52DAFA-1906-42ED-B3C2-DEE6E16A8A2FQ46568443-0B96CBB4-12AB-4DA2-9ED5-72ED68B438ECQ53000354-89CEA1BB-ED4C-4D15-BEA6-D2AA71A5E749
P2860
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
description
im Februar 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 February 2003
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2003
@uk
name
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
@en
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
@nl
type
label
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
@en
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
@nl
prefLabel
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
@en
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
@nl
P356
P1433
P1476
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
@en
P2093
Isabelle Bedrosian
Susan L Tucker
P2888
P356
10.1038/NM0203-152
P407
P577
2003-02-01T00:00:00Z